After Oppenheimer pump job. Will it be a penny stock before the year is over? No efficacy data makes you wonder if aldox is any more effective than Cayenne pepper for treating cancer.
Can you say manipulation?
Then you just know it had to be bad. For example, the trial halt news came on a Friday.
How does that compare to OMT?
Looks like nobody can refute this point. Will low efficacy ultimately doom thus treatment? Even if it gets approved, most people will be inclined to choose meds over surgery, especially if the meds are seen as being more efficacious.
I have to say in this debate, BM wins hands down. BM uses reasoning to discuss the science and reasons why C-Pulse may not be preventing HF deaths. Ex uses and hominem attacks, and seems to base his faith in SSH on a couple of medical opinions he's had in the past as well as the opinion of analysts, and we know analysts tend to be right about 50% of the time. That's being generous.
Can C-Pulse be modified to improve LVEF? Thoughts?
Just another nail in the coffin for Sunshine Heart. Oh well, at least the insiders got rich! God bless America!
I hate to admit it, but I have to agree with BM here. Of course the company is downplaying the seriousnesness, and the analysts seem to be basing their views on the best case scenario.
But doesn't thecclinical study exclude people with those other conditions related to heart failure? Why would they include people like that in the trial?